丙型肝炎基因型 1a的临床试验
总计2343个结果
-
Bader, Ted, M.D.完全的
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
Romark Laboratories L.C.完全的
-
AbbVie完全的
-
HaEmek Medical Center, IsraelAbbVie完全的
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Minority Health and Health Disparities (NIMHD) 和其他合作者完全的
-
Hospital de Clinicas de Porto AlegreMinistry of Health, Brazil; TelessaúdeRS / UFRGS; State Secretary of Health of Rio Grande do Sul主动,不招人
-
Bristol-Myers Squibb完全的
-
TaiwanJ Pharmaceuticals Co., Ltd终止
-
Bristol-Myers Squibb完全的
-
Medical University of Graz撤销
-
Duke UniversityUniversity of North Carolina, Chapel Hill; Durham VA Medical Center完全的
-
Biocad完全的
-
Merck Sharp & Dohme LLC撤销
-
Bristol-Myers Squibb完全的
-
Janssen Pharmaceutica N.V., Belgium完全的
-
University of Missouri, Kansas CityReliant Pharmaceuticals; Saint Luke's Health System Foundation; Truman Medical Center撤销
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Nanogen Pharmaceutical Biotechnology Joint Stock...完全的
-
Debiopharm International SA终止
-
Bristol-Myers SquibbBasel Institute of Clinical Epidemiology (BICE)完全的
-
Bristol-Myers Squibb完全的
-
Vertex Pharmaceuticals Incorporated终止
-
Merck Sharp & Dohme LLC完全的
-
Mitsubishi Tanabe Pharma Corporation完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur; National Hepatology & Tropical Medicine Research Institute撤销
-
Vertex Pharmaceuticals Incorporated完全的
-
University of ManitobaRoche Pharma AG完全的